Patents by Inventor Joanna Mary Redmond

Joanna Mary Redmond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS
    Publication number: 20210206758
    Abstract: The invention relates to compounds of Formula (I): wherein R1, R2 and R3 are as defined in the description and claims, or pharmaceutically acceptable salts thereof, having ?v?6 integrin antagonist activity. The invention also relates to pharmaceutical compositions including a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and to the use of a compound of Formula (I), or a pharmaceutically acceptable salt thereof, in therapy, including in the treatment of a disease or condition for which an ?v?6 integrin antagonist is indicated, in particular the treatment of idiopathic pulmonary fibrosis.
    Type: Application
    Filed: March 20, 2017
    Publication date: July 8, 2021
    Inventors: Niall Andrew ANDERSON, Matthew Howard James CAMPBELL-CRAWFORD, Ashley Paul HANCOCK, Seble LEMMA, John Martin PRITCHARD, Panayiotis Alexandrou PROCOPIOU, Joanna Mary REDMOND, Steven Leslie SOLLIS
  • NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS.
    Publication number: 20190275016
    Abstract: A compound of formula (I): being 4-(3-Fluoro-3-(2-(5, 6, 7, 8-tetrahydro-1, 8-naphthyridin-2-yl) ethyl) pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Inventors: Niall Andrew ANDERSON, Matthew Howard James CAMPBELL-CRAWFORD, Ashley Paul HANCOCK, John Martin PRITCHARD, Joanna Mary REDMOND
  • Compounds ??integrin antagonists
    Patent number: 10342783
    Abstract: A compound of formula (I): being 4-(3-Fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl) ethyl) pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: July 9, 2019
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond
  • NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
    Publication number: 20180271845
    Abstract: A compound of formula (I): being 4-(3-Fluoro-3-(2-(5, 6, 7, 8-tetrahydro-1, 8-naphthyridin-2-yl) ethyl) pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.
    Type: Application
    Filed: March 15, 2018
    Publication date: September 27, 2018
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond
  • Compounds ??integrin antagonists
    Patent number: 10000489
    Abstract: A compound of formula (I): wherein R is H or F; or a salt thereof.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: June 19, 2018
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond
  • Compounds ??integrin antagonists
    Patent number: 9956209
    Abstract: A compound of formula (I): which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: May 1, 2018
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond
  • NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
    Publication number: 20170298063
    Abstract: A compound of formula (I): wherein R is H or F; or a salt thereof.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 19, 2017
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond
  • NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
    Publication number: 20170290817
    Abstract: A compound of formula (I): which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 12, 2017
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond